Published in Bioorg Med Chem on December 01, 2004
GdDO3NI, a nitroimidazole-based T1 MRI contrast agent for imaging tumor hypoxia in vivo. J Biol Inorg Chem (2013) 0.81
Synthesis and characterization of a hypoxia-sensitive MRI probe. Chemistry (2012) 0.78
Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med (2002) 11.38
Preparation and preliminary biological evaluation of 177Lu-labelled hydroxyapatite as a promising agent for radiation synovectomy of small joints. Nucl Med Commun (2006) 1.34
Tocotrienols from palm oil as effective inhibitors of protein oxidation and lipid peroxidation in rat liver microsomes. Mol Cell Biochem (1997) 1.32
Viral hepatitis-related acute liver failure. Am J Gastroenterol (2003) 1.28
Radiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECT. Theranostics (2011) 1.25
Preparation and preliminary studies on 177Lu-labeled hydroxyapatite particles for possible use in the therapy of liver cancer. Nucl Med Biol (2008) 1.17
Production logistics of 177Lu for radionuclide therapy. Appl Radiat Isot (2003) 1.05
177Lu labelled polyaminophosphonates as potential agents for bone pain palliation. Nucl Med Commun (2002) 1.04
Albright's hereditary osteodystrophy. Indian J Pediatr (2006) 1.04
2-Mercaptoacetylglycylglycyl (MAG2) as a bifunctional chelator for 99mTc-labeling of cyclic RGD dimers: effect of technetium chelate on tumor uptake and pharmacokinetics. Bioconjug Chem (2009) 1.01
99mTc-labeled cyclic RGD peptides for noninvasive monitoring of tumor integrin αVβ3 expression. Mol Imaging (2011) 1.01
Preparation and evaluation of a new radiopharmaceutical for radiosynovectomy, 111Ag-labelled hydroxyapatite (HA) particles. Appl Radiat Isot (2007) 0.95
Evaluation of In-Labeled Cyclic RGD Peptides: Effects of Peptide and Linker Multiplicity on Their Tumor Uptake, Excretion Kinetics and Metabolic Stability. Theranostics (2011) 0.95
Feasibility study for production of 175Yb: a promising therapeutic radionuclide. Appl Radiat Isot (2002) 0.93
177Lu-EDTMP: a viable bone pain palliative in skeletal metastasis. Cancer Biother Radiopharm (2008) 0.91
Preparation of patient doses of (177)Lu-DOTA-TATE using indigenously produced (177)Lu: the Indian experience. Cancer Biother Radiopharm (2011) 0.91
Metal-induced neurodegeneration in C. elegans. Front Aging Neurosci (2013) 0.89
The effects of pdr1, djr1.1 and pink1 loss in manganese-induced toxicity and the role of α-synuclein in C. elegans. Metallomics (2014) 0.89
177Lu-labeled cyclic polyaminophosphonates as potential agents for bone pain palliation. Appl Radiat Isot (2002) 0.88
'Reverse discordance' between 68Ga-DOTA-NOC PET/CT and 177Lu-DOTA-TATE posttherapy scan: the plausible explanations and its implications for high-dose therapy with radiolabeled somatostatin receptor analogs. Nucl Med Commun (2011) 0.88
Impact of bifunctional chelators on biological properties of 111In-labeled cyclic peptide RGD dimers. Amino Acids (2010) 0.88
In vivo postirradiation protection by a vitamin E analog, alpha-TMG. Radiat Res (2003) 0.87
Comparative studies of 177Lu-EDTMP and 177Lu-DOTMP as potential agents for palliative radiotherapy of bone metastasis. Appl Radiat Isot (2008) 0.87
Comparison of dissolved and particulate arsenic distributions in shallow aquifers of Chakdaha, India, and Araihazar, Bangladesh. Geochem Trans (2008) 0.85
99mTc-labeled annexin V fragments: a potential SPECT radiopharmaceutical for imaging cell death. Nucl Med Biol (2006) 0.85
175Yb labeled polyaminophosphonates as potential agents for bone pain palliation. Appl Radiat Isot (2004) 0.85
Preparation and in vitro evaluation of radioiodinated bakuchiol as an anti tumor agent. Appl Radiat Isot (2005) 0.85
Nanoceria-PAN composite-based advanced sorbent material: a major step forward in the field of clinical-grade 68Ge/68Ga generator. ACS Appl Mater Interfaces (2010) 0.85
Preparation and preliminary biological evaluation of a novel 109Pd labeled porphyrin derivative for possible use in targeted tumor therapy. Q J Nucl Med Mol Imaging (2007) 0.84
Development of a nano-zirconia based 68Ge/68Ga generator for biomedical applications. Nucl Med Biol (2011) 0.84
Developing a dedicated comprehensive α-radionuclide therapy program: should this be the vision of the atomic energy programs in the next decade? Nucl Med Commun (2016) 0.84
Preparation and biological evaluation of 153Sm-DOTMP as a potential agent for bone pain palliation. Nucl Med Commun (2004) 0.83
188Re-labeled hydroxyapatite particles for radiation synovectomy. Appl Radiat Isot (2003) 0.83
Biologic evaluation of a novel 188Re-labeled porphyrin in mice tumor model. Cancer Biother Radiopharm (2010) 0.83
[(186/188)Re] rhenium-ethylene dicysteine (Re-Ec): preparation and evaluation for possible use in endovascular brachytherapy. Nucl Med Biol (2000) 0.83
Long-term evaluation of 'BARC 68Ge/68Ga generator' based on the nanoceria-polyacrylonitrile composite sorbent. Cancer Biother Radiopharm (2013) 0.83
Polymer embedded nanocrystalline titania sorbent for 99Mo-99mTc generator. J Nanosci Nanotechnol (2008) 0.82
Genome-Wide Analyses of Metal Responsive Genes in Caenorhabditis elegans. Front Genet (2012) 0.82
A novel electrochemical technique for the production of clinical grade 99mTc using (n, gamma)99Mo. Nucl Med Biol (2009) 0.82
Cellular transport and homeostasis of essential and nonessential metals. Metallomics (2012) 0.82
Insights from Caenorhabditis elegans on the role of metals in neurodegenerative diseases. Metallomics (2011) 0.82
In vivo radioprotection by alpha-TMG: preliminary studies. Mutat Res (2001) 0.81
Protection of DNA and microsomal membranes in vitro by Glycyrrhiza glabra L. against gamma irradiation. Phytother Res (2002) 0.81
Synthesis and preliminary bioevaluation of 99mTc(CO)3-17α-triazolylandrost-4-ene-3-one derivative prepared via click chemistry route. Cancer Biother Radiopharm (2011) 0.81
Practicality of production of ³²P by direct neutron activation for its utilization in bone pain palliation as Na₃[³²P]PO₄. Cancer Biother Radiopharm (2013) 0.81
Radiation protection of DNA and membrane in vitro by extract of Hemidesmus indicus. Phytother Res (2005) 0.81
Genetic alterations in the coding region of the bak gene in uterine cervical carcinoma. Br J Cancer (2003) 0.81
Bioevaluation of radioactive bandages in a murine model of melanoma. Int J Radiat Biol (2003) 0.80
Early-life exposure to methylmercury in wildtype and pdr-1/parkin knockout C. elegans. Neurochem Res (2013) 0.80
An estradiol-conjugate for radiolabelling with 177Lu: an attempt to prepare a radiotherapeutic agent. Bioorg Med Chem (2005) 0.80
¹⁷⁷Lu-EDTMP for treatment of bone pain in patients with disseminated skeletal metastases. J Nucl Med Technol (2014) 0.80
On the preparation of a therapeutic dose of 177Lu-labeled DOTA-TATE using indigenously produced 177Lu in medium flux reactor. Appl Radiat Isot (2006) 0.80
Preparation and evaluation of 90 Y skin patches for therapy of superficial tumours in mice. Nucl Med Commun (2002) 0.80
Molecular Imaging of Breast Cancer: Role of RGD Peptides. Mini Rev Med Chem (2015) 0.79
Preparation and bioevaluation of 166Ho labelled hydroxyapatite (HA) particles for radiosynovectomy. Nucl Med Biol (2002) 0.79
Development of an electrochemical 90 Sr-90 Y generator for separation of 90 Y suitable for targeted therapy. Nucl Med Biol (2008) 0.79
Development of a new design (125)I-brachytherapy seed for its application in the treatment of eye and prostate cancer. Appl Radiat Isot (2009) 0.79
Radiolabeling of umbilical cord-derived mesenchymal stem cells for in vivo tracking. Cancer Biother Radiopharm (2012) 0.79
Detailed evaluation on the effect of metal ion impurities on complexation of generator eluted 68Ga with different bifunctional chelators. Nucl Med Biol (2012) 0.79
Unusual scaling in the rheology of branched wormlike micelles formed by cetyltrimethylammonium bromide and sodium oleate. J Phys Chem B (2011) 0.79
Preparation of 177Lu-labeled oxine in lipiodol as a possible agent for therapy of hepatocellular carcinoma: a preliminary animal study. Cancer Biother Radiopharm (2010) 0.79
Peptide receptor radionuclide therapy: an overview. Cancer Biother Radiopharm (2015) 0.78
Bioevaluation studies of 32P incorporated mould brachytherapy sources for potential application in treatment of superficial tumors. Nucl Med Commun (2008) 0.78
Preparation of 99mTc(CO)3-Carboxymethylthioethyl iminodiacetic acid and evaluation as a potential renal imaging agent. Curr Radiopharm (2012) 0.78
Evaluation of 90Y-DTPA and 90Y-DOTA for potential application in intra-vascular radionuclide therapy. Appl Radiat Isot (2002) 0.78
99mTc carbonyl t-butyl isonitrile: a potential new agent for myocardial perfusion imaging. Nucl Med Commun (2005) 0.78
Modification of PLGA nanoparticles for improved properties as a 99mTc-labeled agent in sentinel lymph node detection. Cancer Biother Radiopharm (2013) 0.78